86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02676947 (ClinicalTrials.gov)	January 2016	21/12/2015	A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension	A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Tocilizumab	Papworth Hospital NHS Foundation Trust	Roche Pharma AG;National Institute for Health Research, United Kingdom	Completed	18 Years	70 Years	All	29	Phase 2	United Kingdom
2	EUCTR2015-002799-26-GB (EUCTR)	27/10/2015	21/09/2015	A therapeutic trial of blockade of interleukin-6 using the drug Tocilizumabin pulmonary arterial hyp ...	TRANSFORM-UK: A Therapeutic Open Label Study of Tocilizumabin the Treatment of Pulmonary Arterial Hy ...	Pulmonary arterial hypertension;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]	Trade Name: RoActemra INN or Proposed INN: Tocilizumab Other descriptive name: n/a	Papworth Hospital NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	26	Phase 2	United Kingdom

First Previous1Next Last